95006-00-1

Upstream product

• 100-52-7 benzaldehyde 
• 579-74-8 2-Methoxyacetophenone 
• 40524-62-7 1-(2-methoxyphenyl)-3-phenyl-2-propene-1-one 
• 59-88-1 phenylhydrazine hydrochloride 

Downstream Products

• 1426533-91-6 C₂₆H₂₄N₂O₃ 
• 1426533-90-5 4-(2-(1,5-diphenyl-1H-pyrazol-3-yl)phenoxy)butanoic acid 
• 1426534-15-7 3-(2-methoxyphenyl)-1,5-diphenyl-1H-pyrazole 
• 19726-10-4 2-(1-phenyl-5-phenyl-1H-pyrazol-3-yl)phenol 
• 1310361-49-9 2-(2'-(1,5-diphenyl-1H-pyrazol-3-yl)biphenyl-3-yloxy)acetate acid 
• 1310361-44-4 C₃₁H₂₆N₂O₃ 
• 1426533-83-6 C₂₂H₁₅F₃N₂O₃S 

Relevant academic research and scientific papers

Spectroscopic studies of aryl substituted 1-phenyl-2-pyrazolines: Steric and electronic substitution effects

A series of aryl substituted 1-phenyl-2-pyrazolines containing electron-donating and electron-withdrawing substituents on different positions of the C3– or C5-aryl groups were synthesized and their steric and electronic effects on ch

Structure-guided design, synthesis and in vitro evaluation of a series of pyrazole-based fatty acid binding protein (FABP) 3 ligands

We designed a series of pyrazole-based carboxylic acids as candidate ligands of heart fatty acid binding protein (H-FABP, or FABP3), based on a comparison of the X-ray crystallographic structures of adipocyte fatty acid binding protein (FABP4)-selective inhibitor (BMS309403) complex and FABP3-elaidic acid complex. Some of the synthesized compounds exhibited dual FABP3/4 ligand activity, and some exhibited selectivity for FABP3.